September 28, 2012
CEO says the acquisition is part of Medtronic's goal of globalization.
The device is the next-generation version of Clearbridge's ClearCell System.
The agency's OK comes following a warning letter earlier in the year.
The newly created position is meant to drive the development of Utah's life sciences sector.
The new location will provide a nexus for China and other regional clients.
The medical device giant is adding BridgePoint to its Interventional Cardiology Division.
The two companies are focused on the treatment of epilepsy.
Device now can be used in patients 65 and older.
The new hire will focus heavily on R&D for pharmaceutical and medical device customers.
The trade fairs in Germany provide a forum for players from all corners of the medical technology industry to come together.
The needles are targeted toward diabetes patients who fear needles due to pain or discomfort.
The system is geared toward women with dense breast tissue.
The company manufactures podiatric devices.
The devices are available in both the U.S. and the E.U.
Iris will join Danaher's Beckman Coulter diagnostics business.
Latest delay could cost the company NYSE listing.
Officials claim the space of interoperability needs to be developed.
The New Hampshire facility is hoped to provide 25 new jobs.
Rep. Paulsen and industry advocates believe government is unprepared for the implementation of the tax.
The facility is the company’s first in Latin America.
The system is relatively affordable, a big attraction for emerging markets.
New hire brings experience in product innovation.
Citing the medical device excise tax, the company looks outside the United States for new business opportunities.
Research company details how the market share is divided globally.
The new version of the Impella is doubly powerful, company claims.
Entries may still be submitted until the end of October.
Researchers believe Intact Vascular’s new technology will not best existing technology.
The CE Mark approves the system to treat chronic pain and patients who need MRIs.
This report is part of a slew of steps the FDA is taking to keep the promises of MDUFA.
The device is being updated, and the new version will be re-submitted for approval.
The device received European approval earlier this year.
Restore Medical Solutions was one of the first companies to participate in the accelerated device development program.
The cover is intended specifically for obese patients.
The news comes soon after the release of a new Arrow catheter earlier this month.
The company received the CE Mark a year after it received FDA clearance.
The investment will go toward the development of a blood flow monitoring device.
Specialty Manufacturing’s expansion more than doubles its plant size.
The new Canton location will manufacture polymer tubing.
The two companies will join forces on a self-injection drug delivery system.
The company hopes to be one of the few welding companies to achieve the medical device ISO standard.
Please visit our sister sites:
The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.